0ACX fundamentals
An in-depth look to CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS operating, investing, and financing activities
0ACX free cash flow for Q3 24 is -21.84 M USD. For 2023, 0ACX free cash flow was -161.13 M USD and operating cash flow was -160.96 M USD.
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM